Ueno A, Ohishi S, Kitagawa T, Katori M
Adv Exp Med Biol. 1979;120A:195-202. doi: 10.1007/978-1-4757-0926-1_19.
An enzyme immunoassay of bradykinin was developed by using beta-D-galactosidase as a labeling enzyme. Bradykinin was conjugated to beta-D-galactosidase with a new coupling agent of a hetero bis-functional type, N-(m-maleimidobenzoyloxy)-succinimide (MBS). Antisera were obtained from rabbits immunized with bradykinin linked to albumins (ovalbumin or bovine serum albumin) with toluene-2,4-diisocyanate. Double antibody method was employed to separate the antibody-bound antigen from free. The enzyme activity in the precipitate was measured with a fluorogenic substrate, 4-methyl-umbelliferyl-beta-D-galactoside. This assay is based on heterogeneous competitive binding between unlabeled and labeled antigens, so that unlabeled bradykinin reduces binding of bradykinin-enzyme conjugates to the antibody. A standard inhibition curve was linear between 3 and 300 ng bradykinin/assay tube.
通过使用β-D-半乳糖苷酶作为标记酶,开发了一种缓激肽的酶免疫测定法。缓激肽通过一种新型杂双功能型偶联剂N-(间马来酰亚胺苯甲酰氧基)琥珀酰亚胺(MBS)与β-D-半乳糖苷酶偶联。用甲苯-2,4-二异氰酸酯将与白蛋白(卵清蛋白或牛血清白蛋白)连接的缓激肽免疫兔子,获得抗血清。采用双抗体法将结合抗体的抗原与游离抗原分离。用荧光底物4-甲基伞形酮基-β-D-半乳糖苷测定沉淀物中的酶活性。该测定基于未标记抗原和标记抗原之间的异相竞争结合,因此未标记的缓激肽会减少缓激肽-酶偶联物与抗体的结合。标准抑制曲线在3至300 ng缓激肽/测定管之间呈线性。